PMID: 16613565Apr 15, 2006Paper

Current options in the treatment of mast cell mediator-related symptoms in mastocytosis

Inflammation & Allergy Drug Targets
Luis EscribanoLawrence B Schwartz

Abstract

Patients with mastocytosis have symptoms related to the tissue response to the release of mediators from mast cells (MC), local mast cell burden or associated non-mast cell hematological disorders. MC contain an array of biologically active mediators in their granules, which are preformed and stored. MC are also able to produce newly generated membrane-derived lipid mediators and are a source of multifunctional cytokines. Mediator-related symptoms can include pruritus, flushing, syncope, gastric distress, nausea and vomiting, diarrhea, bone pain and neuropsychiatric disturbances; these symptoms are variably controlled by adequate medications. Management of patients within all categories of mastocytosis includes: a) a careful counseling of patients (parents in pediatric cases) and care providers, b) avoidance of factors triggering acute mediator release, c) treatment of acute and chronic MC-mediator symptoms and, if indicated, d) an attempt for cytoreduction and treatment of organ infiltration by mast cells.

Citations

Dec 10, 2008·Current Allergy and Asthma Reports·Ulrich R Müller, Gabrielle Haeberli
Mar 25, 2011·The New England Journal of Medicine·Mandakolathur R MuraliRobert P Hasserjian
May 18, 2011·International Archives of Allergy and Immunology·Peter ValentMichel Arock
Oct 4, 2008·Journal of Smooth Muscle Research = Nihon Heikatsukin Gakkai Kikanshi·Patrícia de S RossignoliAgnaldo B Chies
Jun 21, 2014·Current Allergy and Asthma Reports·A MatitoL Escribano
Sep 9, 2010·Medizinische Klinik·Jürgen HomannGerhard J Molderings
Jul 12, 2012·Expert Review of Hematology·Wolfgang R Sperr, Peter Valent
Sep 21, 2013·Expert Opinion on Pharmacotherapy·Juan Carlos CardetMin Jung Lee
Sep 9, 2008·Expert Opinion on Biological Therapy·Mahin Khatami
Feb 20, 2016·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·M RossiniD Gatti
Apr 22, 2014·Immunology and Allergy Clinics of North America·Frank SiebenhaarSigurd Broesby-Olsen
Nov 23, 2013·Immunology and Allergy Clinics of North America·Melody C CarterHirsh D Komarow
Apr 30, 2009·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·U R Müller
Jun 9, 2007·British Journal of Haematology·Alberto OrfaoUNKNOWN REMA
Jan 5, 2011·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·T A RamaM H Fernandes
May 14, 2011·Journal of the European Academy of Dermatology and Venereology : JEADV·V BrazzelliG Borroni
Oct 30, 2013·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·T GülenG Nilsson
Nov 7, 2015·Mediators of Inflammation·Gregor HoermannPeter Valent
Nov 23, 2006·The International Journal of Biochemistry & Cell Biology·Shoko IwakiAlasdair M Gilfillan
Mar 11, 2015·European Journal of Haematology·Michel ArockPeter Valent
Jul 4, 2015·Current Allergy and Asthma Reports·A Matito, M Carter
Feb 26, 2014·The Journal of Allergy and Clinical Immunology. in Practice·Susan JenningsCem Akin
May 2, 2016·Naunyn-Schmiedeberg's Archives of Pharmacology·Gerhard J MolderingsLawrence B Afrin
May 21, 2010·Current Opinion in Allergy and Clinical Immunology·Patrizia BonadonnaUlrich Müller
Sep 18, 2007·Current Opinion in Allergy and Clinical Immunology·Matthew Greenhawt, Cem Akin
Jun 2, 2017·Current Opinion in Allergy and Clinical Immunology·Theo Gülen, Cem Akin
May 4, 2012·International Journal of Laboratory Hematology·I Alvarez-TwoseL Escribano
Jan 31, 2017·Annual Review of Pathology·Dean D Metcalfe, Yoseph A Mekori
Dec 13, 2016·Current Treatment Options in Allergy·Merel C OnnesJoanne N G Oude Elberink
Jul 26, 2017·Frontiers in Immunology·David González-de-Olano, Iván Álvarez-Twose
Apr 28, 2019·Current Allergy and Asthma Reports·Elise CoulsonCem Akin
Apr 26, 2017·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Iolanda Conde-FernandesMargarida Lima
Jun 25, 2021·The Journal of Allergy and Clinical Immunology. in Practice·Theo GülenPeter Valent

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.